There is a dirty secret at the heart of the Venture Capital industry , one that is rarely whispered at LP annual meetings but is screamed in the silence of shut-down startups : Most VCs are not in the business of generating returns . They are in the business of generating fees . In the last decade, the asset class has drifted away from the craft of company building and into a financial engineering game defined by a simple, toxic loop: Markup, Markup , AUM, AUM . This cyc

If you listen to the whisper network of Limited Partners , Family Offices , and Funds of Funds, a specific set of heuristics for Venture Capital success begins to emerge. Recently, a compilation of these "Predictors of Success" circulated , highlighting what capital allocators actually look for when choosing General Partners . The advice included: On Manners:  If you ask for money, adhere to the LP’s calendar. The “ warm intro ” followed by an assistant battle is a proxy f

There is a prevailing dogma in Venture Capital , often codified in the clean rows of a spreadsheet, that treats startups as Discounted Cash Flow (DCF) exercises from day zero. The logic goes: if the math of portfolio construction demands a 200x return to offset the power law , then the injection of capital is the mechanism that drives the startup toward that multiple. This view fundamentally misunderstands the physics of company building. It assumes that money is an acti

The venture capital industry is splitting in two. On one side, we have Hard/Deep Tech  (energy, semiconductors, biotech), which remains a capital-intensive game of Technical De-risking  requiring significant upfront checks. But on the other side, we are witnessing the Miniaturization of the Startup . For sectors like software , e-commerce, and digital services, the traditional "Seed Round" has become an obsolete relic. In an economy reshaped by Agentic AI and a collapsing c

For decades, the venture capital industry has celebrated the Sniper . In the traditional model, the General Partner is a hunter. They sit in a bunker of " exclusive access ," waiting for a high-resolution target—the Unicorn —to walk into their crosshairs. They have a fixed amount of ammunition ( the fund size ) and a ticking clock ( the 10-year life cycle ). Success is measured by the "kill"—the exit event that returns capital to LPs . But as we have argued in Why Venture

A common critique of systematic , programmatic funding is that it is a " SaaS -only" strategy. The logic goes: "You can track the 'Slope' of an app or a shipping platform because the data is digital. But you can't automate the funding of a fusion reactor, a biotech lab, or a semiconductor factory." This is a failure of imagination. In reality, capital-intensive sectors are where the traditional 10-year venture fund does the most damage—and where the Continuous Capital  mode

In our previous discussions, we established a painful truth: The traditional venture capital "Exit" is often a failure of compounding . When a VC forces a portfolio company to sell to a legacy incumbent or rush into a premature IPO to return capital to LPs , they aren't "capturing value"—they are liquidating a growth engine. They are stopping the clock exactly when the math of compounding starts to get interesting. At Meritocratic.Capital , our blueprint is designed to

In the mid-20th century, the tobacco industry operated on a " polite fiction ." Behind closed doors, the science was clear: the product was harmful. But publicly, the marketing was about glamour, lifestyle, and "doctor-recommended" filters. The incentives—billions in predictable cash flow—were too powerful to allow for a pivot to a healthier alternative until the entire system was forced to change. The venture capital industry is currently in its "Tobacco Era." Ask any exp